An Exploration of Key Issues in IBD: A CME/CE-Certified Microlearning Series

Download All
Learn about the latest guideline-recommended therapies for initial induction treatment of moderate to severe UC and CD
Bruce E. Sands, MD, MS

Early Induction Therapy for IBD

In this concise video, review a synthesis of recommendations from AGA and ACG guidelines on the treatment of moderate to severe UC and CD, and hear expert discussion on the rationale for early induction therapy with a biologic.

Bruce E. Sands, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: April 26, 2021 Expired: No longer available for credit

Learn about current guideline recommendations for the treatment of moderate to severe UC and CD, including the rationale for combination therapy.

Bruce E. Sands, MD, MS Released: April 26, 2021

With advances in novel biologic and small molecule treatment options, new diagnostics, and increasingly complex treatment algorithms, STRIDE-II extends on the previous STRIDE recommendations to help define reasonable treatment targets for IBD.

Bruce E. Sands, MD, MS Released: May 5, 2021
Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings